Asthma and Allergy Foundation of America (AAFA) and IMPACT DC Partner on Bridging Health Disparities Gap
08 oct. 2020 13h22 HE
|
Asthma and Allergy Foundation of America
Washington D.C., Oct. 08, 2020 (GLOBE NEWSWIRE) -- In the United States, the burden of asthma falls disproportionately on poor, low-wealth, and minority populations. Decades of research and public...
Cross Keys Capital Advises Atlanta Allergy & Asthma Clinic on Partnership with Southern Ear, Nose, Throat & Allergy Partners
30 sept. 2020 17h59 HE
|
Cross Keys Capital, LLC.
Fort Lauderdale, Florida, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Cross Keys Capital served as the exclusive M&A advisor to Atlanta Allergy & Asthma Clinic ("Atlanta Allergy") in its partnership...
Global Aerosol delivery devices market to Hit $46.72 Billion by 2027: AMR
30 sept. 2020 08h50 HE
|
Allied Market Research
Portland, OR , Sept. 30, 2020 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global aerosol delivery devices market generated $31.46 billion in 2019, and is...
Hofseth Biocare ASA: ANNOUNCES THE USE OF A VIRTUAL PLATFORM TO RECRUIT COVID-19 PATIENTS IN CANADA TO THE PHASE 2 TRIAL. WILL ALSO ASSESS THE IMPACT OF OMEGO ON HOSPITALISED PATIENTS WITH SEVERE FORMS OF COVID-19 IN MEXICO AND BRAZIL
24 sept. 2020 02h56 HE
|
Hofseth Biocare ASA
Reference is made to the stock exchange notice on 26 May 2020 and 30 June 2020. Hofseth BioCare ASA (“HBC”) announces that the first part of its accelerated phase 2 trial of CARDIO™ soft gels for the...
AAFA Rolls Out National Roadmap to Address Serious Asthma Disparities Impacting Black and Hispanic Americans
16 sept. 2020 09h00 HE
|
Asthma and Allergy Foundation of America
Washington D.C., Sept. 16, 2020 (GLOBE NEWSWIRE) -- A new, comprehensive report from the Asthma and Allergy Foundation of America (AAFA) shows stubbornly persistent disparities in asthma for Black...
Hofseth Biocare ASA: New study highlights the potential of OmeGo® as a prophylactic therapy for Asthma and COPD
01 sept. 2020 06h49 HE
|
Hofseth Biocare ASA
An in-vitro study published in the journal Functional Foods in Health and Disease (2020; 10(8):357-367) shows the therapeutic potential of HBC’s OmeGo® salmon oil for the treatment of certain types of...
Equillium Announces Closing of Public Offering of Common Stock
18 août 2020 16h05 HE
|
Equillium
LA JOLLA, Calif., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders,...
Asthma and Allergy Foundation of America (AAFA) Appoints Melanie Carver Chief Mission Officer
06 août 2020 08h53 HE
|
Asthma and Allergy Foundation of America
Washington, D.C., Aug. 06, 2020 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) is excited to announce Melanie Carver has been named Chief Mission Officer of the...
AB Science annonce que de nouveaux résultats publiés dans la revue médicale évaluée par des pairs Journal of Alzheimer’s Disease renforcent la plausibilité du mode d’action du masitinib dans la maladie d’Alzheimer
08 juil. 2020 02h57 HE
|
AB Science
Paris, 8 juillet 2020, 9h De nouveaux résultats publiés dans la revue médicale évaluée par des pairsJournal of Alzheimer’s Disease renforcent la plausibilité du mode d’actiondu masitinib dans...
AB Science announces that new results published in the peer-reviewed Journal of Alzheimer's Disease support masitinib’s potential mode of action in Alzheimer’s Disease
08 juil. 2020 02h57 HE
|
AB Science
Paris, 08 July 2020, 9am New results published in the peer-reviewed Journal of Alzheimer's Diseasesupport masitinib’s potential mode of action in Alzheimer’s Disease ...